New study finds Moderna vaccinated more likely to be reinfected
A new study on the efficacy of the Moderna vaccine has found that recipients are more likely to lack antibodies crucial to preventing repeat infection compared to those with natural immunity.

TCS Wire

May 9, 2022

A new study on the efficacy of the Moderna vaccine has found that recipients are more likely to lack antibodies crucial to preventing repeat infection compared to those with natural immunity.

Researchers analyzing the vaccine efficacy of Moderna looked at 1,789 participants (1,298 placebo recipients and 491 vaccine recipients) that were 18 years old or older with no known history of SARS-CoV-2 infection and at appreciable risk of SARS-CoV-2 infection and/or high risk of severe Covid-19. They ultimately found that those not inoculated with Moderna had more antibodies after being infected than those who received the vaccine.

“Among participants in the mRNA-1273 vaccine efficacy trial with PCR-confirmed Covid-19, anti-nucleocapsid antibody seroconversion at the time of study unblinding (median 53 days post-diagnosis and 149 days post-enrollment) occurred in 40% of the mRNA-1273 vaccine recipients vs. 93% of the placebo recipients, a significant difference,” the researchers conclude.

According to Children’s Health Defense, “Anti-nucleocapsid antibodies are antibodies specific to the nucleocapsid portion of the SARS-CoV-2 virus, the virus responsible for COVID-19.”

They further report that the findings suggest that those who received the Moderna vaccine are more likely to be reinfected, perhaps “indefinitely.”

“The authors’ findings, which are corroborated by U.K. data that demonstrate the rates of infection are significantly higher in the vaccinated, suggest Moderna knew of this safety signal in 2020 when the vaccine maker was conducting its trials,” writes Children’s Health Defense.

“…. Specifically, the study implies that the reduced ability of a vaccinated individual to produce antibodies to other portions of the virus may lead to a greater risk of future infections in the vaccinated compared to the unvaccinated.”

Overall, the researchers’ findings suggest that natural infection is likely to provide more robust protection when an individual is exposed to COVID-19 in the future.

Share this story

Help Keep your News Free

Share this story

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

It appears side effects weren’t so rare after all, and AstraZeneca knows it. 

Mike Campbell

May 22, 2024

Trending News

BC Supreme Court Justice Simon Coval ruled that extended vaccine mandates for healthcare workers were justified, adding that the mandates did obstruct certain freedoms, but those freedoms were secondary to “essential public health objectives.” 

Alexa Posa

May 15, 2024

Trending News

Arbitrator rules against Canada Post’s policy of suspending unvaccinated remote workers without pay, setting the stage for compensation negotiations.

TCS Wire

May 14, 2024

Trending News

Canadians who refused to comply with the mandated ArriveCAN app during the COVID-19 pandemic had their charges and fines dropped or substantially reduced.

Alexa Posa

May 13, 2024

Trending News

Pfizer has agreed to settle over 10,000 lawsuits that have been filed against it over allegedly failing to report Zantac’s possible link to cancer.

TCS Wire

May 9, 2024

Trending News

“If anything happens to me, it is Big Pharma, Big Tech, Big Gov.”

Keean Bexte

May 8, 2024

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.